Pinterest To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Monday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts have updated their price targets and ratings for several US-listed companies, including Skechers, Pinterest, Apellis Pharmaceuticals, LyondellBasell, Cigna, Markel, Mattel, SkyWest, AbbVie, and Dover Corporation. These changes reflect analysts' latest views on these companies' stock performance, with adjustments made to price targets and stock ratings based on recent market activities and company performance.
February 05, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan downgraded Mattel from Overweight to Neutral, reducing the price target from $24 to $19. Shares rose 4.1% recently.
The downgrade and price target cut by JP Morgan suggest a cautious outlook, but the recent share price increase may indicate a neutral short-term impact as the market adjusts.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEUTRAL IMPACT
Jefferies downgraded Markel from Buy to Hold, cutting the price target from $1,680 to $1,500. Shares gained 1.2% recently.
The downgrade and price target reduction by Jefferies suggest caution, but the recent share price gain indicates market factors may have already adjusted, leading to a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEUTRAL IMPACT
Raymond James lowered Skechers' price target from $68 to $66 but maintained an Outperform rating. Skechers shares declined 10.3% recently.
The slight decrease in price target suggests a cautious but still positive outlook from Raymond James. The recent share price decline may already reflect market adjustments, leading to a neutral short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Raymond James raised AbbVie's price target from $181 to $189, maintaining an Outperform rating. Shares rose 0.6% recently.
The increase in AbbVie's price target by Raymond James suggests continued confidence in the company's performance, likely contributing to positive short-term price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Jefferies upgraded Apellis Pharmaceuticals from Hold to Buy, raising the price target from $68 to $80. Shares rose 0.7% recently.
The upgrade to Buy and the increase in price target by Jefferies suggest a strong confidence in Apellis Pharmaceuticals' potential, likely leading to positive short-term price movement.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Cantor Fitzgerald upgraded Cigna from Neutral to Overweight, raising the price target from $334 to $372. Shares rose 5.4% recently.
The upgrade and significant price target increase for Cigna by Cantor Fitzgerald reflect a strong positive sentiment, likely contributing to continued short-term upward price movement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Barclays raised Dover's price target from $150 to $163, maintaining an Equal-Weight rating. Shares rose 1.4% recently.
The price target increase for Dover by Barclays, despite the Equal-Weight rating, suggests a positive adjustment to the company's valuation, likely leading to short-term positive price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
JP Morgan upgraded LyondellBasell from Neutral to Overweight, increasing the price target from $95 to $100. Shares fell 1.9% recently.
Despite the recent share price decline, the upgrade and increased price target from JP Morgan indicate a positive outlook, suggesting potential for recovery and short-term gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Keybanc raised Pinterest's price target from $37 to $48, maintaining an Overweight rating. Pinterest shares rose 5.8% recently.
The significant increase in Pinterest's price target and the recent share price rise indicate a strong positive outlook from Keybanc, suggesting potential short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
TD Cowen upgraded SkyWest from Market Perform to Outperform, raising the price target from $55 to $68. Shares gained 8.2% recently.
The upgrade and price target increase for SkyWest by TD Cowen indicate a strong positive outlook, likely leading to further short-term upward momentum in share price.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90